SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Françoise Kraeber-Bodéré, Jacques Barbet, Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine, Frontiers in Medicine, 2014, 1,

    CrossRef

  2. 2
    Christian Hess, Dario Venetz, Dario Neri, Emerging classes of armed antibody therapeutics against cancer, MedChemComm, 2014, 5, 4, 408

    CrossRef

  3. 3
    Federica Zoratto, L. Rossi, E. Giordani, M. Strudel, A. Papa, S. Tomao, From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors, Tumor Biology, 2014, 35, 9, 8471

    CrossRef

  4. 4
    Floor C. J. van de Watering, Mark Rijpkema, Marc Robillard, Wim J. G. Oyen, Otto C. Boerman, Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry, Frontiers in Medicine, 2014, 1,

    CrossRef

  5. 5
    Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Rousseau, Thomas Eugène, Amandine Pallardy, Eric Frampas, Thomas Carlier, Ludovic Ferrer, Joëlle Gaschet, François Davodeau, Jean-François Gestin, Alain Faivre-Chauvet, Jacques Barbet, Michel Chérel, Radioimmunoconjugates for the Treatment of Cancer, Seminars in Oncology, 2014, 41, 5, 613

    CrossRef

  6. 6
    George Sgouros, David M. Goldenberg, Radiopharmaceutical therapy in the era of precision medicine, European Journal of Cancer, 2014, 50, 13, 2360

    CrossRef

  7. 7
    Suxia Han, Guihua Jin, Lijuan Wang, Meng Li, Chenchen He, Xijing Guo, Qing Zhu, The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  8. 8
    Ruth A Bryan, Zewei Jiang, Thomas Jandl, Julius Strauss, Wade Koba, Chukwuemeka Onyedika, Alfred Morgenstern, Frank Bruchertseifer, Alan L Epstein, Ekaterina Dadachova, Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA, Expert Review of Anticancer Therapy, 2014, 14, 10, 1243

    CrossRef

  9. 9
    Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch, OncoImmunology, 2014, 3, 1, e27048

    CrossRef

  10. 10
    M.R. Jackson, N. Falzone, K.A. Vallis, Advances in Anticancer Radiopharmaceuticals, Clinical Oncology, 2013, 25, 10, 604

    CrossRef

  11. 11
    R Schoffelen, O C Boerman, D M Goldenberg, R M Sharkey, C M L van Herpen, G M Franssen, W J McBride, C-H Chang, E A Rossi, W T A van der Graaf, W J G Oyen, Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results, British Journal of Cancer, 2013, 109, 4, 934

    CrossRef

  12. 12
    Isabelle Navarro-Teulon, Catherine Lozza, André Pèlegrin, Eric Vivès, Jean-Pierre Pouget, General overview of radioimmunotherapy of solid tumors, Immunotherapy, 2013, 5, 5, 467

    CrossRef

  13. 13
    David V Gold, Guy Newsome, Donglin Liu, David M Goldenberg, Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin, Molecular Cancer, 2013, 12, 1, 143

    CrossRef